Reason and reality-identifying barriers to patient enrolment for clinical trials in invasive candidiasis.
Saved in:
| Title: | Reason and reality-identifying barriers to patient enrolment for clinical trials in invasive candidiasis. |
|---|---|
| Authors: | Sprute R; Department I of Internal Medicine, University of Cologne, Faculty of Medicine and University Hospital Cologne, Excellence Center for Medical Mycology (ECMM), Cologne, NRW, Germany.; University of Cologne, Faculty of Medicine and University Hospital Cologne, Chair Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, NRW, Germany.; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, NRW, Germany., Grothe JH; Department I of Internal Medicine, University of Cologne, Faculty of Medicine and University Hospital Cologne, Excellence Center for Medical Mycology (ECMM), Cologne, NRW, Germany.; University of Cologne, Faculty of Medicine and University Hospital Cologne, Chair Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, NRW, Germany.; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, NRW, Germany., Heringer S; Department I of Internal Medicine, University of Cologne, Faculty of Medicine and University Hospital Cologne, Excellence Center for Medical Mycology (ECMM), Cologne, NRW, Germany.; University of Cologne, Faculty of Medicine and University Hospital Cologne, Chair Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, NRW, Germany.; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, NRW, Germany., Cornely OA; Department I of Internal Medicine, University of Cologne, Faculty of Medicine and University Hospital Cologne, Excellence Center for Medical Mycology (ECMM), Cologne, NRW, Germany.; University of Cologne, Faculty of Medicine and University Hospital Cologne, Chair Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, NRW, Germany.; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, NRW, Germany.; University of Cologne, Faculty of Medicine and University Hospital Cologne, Clinical Trials Centre Cologne (ZKS Köln), Cologne, NRW, Germany.; University of Cologne, Faculty of Medicine and University Hospital Cologne, Center for Molecular Medicine Cologne (CMMC), Cologne, Germany. |
| Source: | The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2022 Nov 28; Vol. 77 (12), pp. 3475-3481. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN: 1460-2091 (Electronic) Linking ISSN: 03057453 NLM ISO Abbreviation: J Antimicrob Chemother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36214051 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Reason and reality-identifying barriers to patient enrolment for clinical trials in invasive candidiasis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Sprute+R%22">Sprute R</searchLink>; Department I of Internal Medicine, University of Cologne, Faculty of Medicine and University Hospital Cologne, Excellence Center for Medical Mycology (ECMM), Cologne, NRW, Germany.; University of Cologne, Faculty of Medicine and University Hospital Cologne, Chair Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, NRW, Germany.; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, NRW, Germany.<br /><searchLink fieldCode="AU" term="%22Grothe+JH%22">Grothe JH</searchLink>; Department I of Internal Medicine, University of Cologne, Faculty of Medicine and University Hospital Cologne, Excellence Center for Medical Mycology (ECMM), Cologne, NRW, Germany.; University of Cologne, Faculty of Medicine and University Hospital Cologne, Chair Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, NRW, Germany.; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, NRW, Germany.<br /><searchLink fieldCode="AU" term="%22Heringer+S%22">Heringer S</searchLink>; Department I of Internal Medicine, University of Cologne, Faculty of Medicine and University Hospital Cologne, Excellence Center for Medical Mycology (ECMM), Cologne, NRW, Germany.; University of Cologne, Faculty of Medicine and University Hospital Cologne, Chair Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, NRW, Germany.; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, NRW, Germany.<br /><searchLink fieldCode="AU" term="%22Cornely+OA%22">Cornely OA</searchLink>; Department I of Internal Medicine, University of Cologne, Faculty of Medicine and University Hospital Cologne, Excellence Center for Medical Mycology (ECMM), Cologne, NRW, Germany.; University of Cologne, Faculty of Medicine and University Hospital Cologne, Chair Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, NRW, Germany.; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, NRW, Germany.; University of Cologne, Faculty of Medicine and University Hospital Cologne, Clinical Trials Centre Cologne (ZKS Köln), Cologne, NRW, Germany.; University of Cologne, Faculty of Medicine and University Hospital Cologne, Center for Molecular Medicine Cologne (CMMC), Cologne, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227513617%22">The Journal of antimicrobial chemotherapy</searchLink> [J Antimicrob Chemother] 2022 Nov 28; Vol. 77 (12), pp. 3475-3481. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>7513617 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1460-2091 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203057453%22">03057453 </searchLink><i>NLM ISO Abbreviation: </i>J Antimicrob Chemother <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36214051 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/jac/dkac344 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 3475 Titles: – TitleFull: Reason and reality-identifying barriers to patient enrolment for clinical trials in invasive candidiasis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Sprute R – PersonEntity: Name: NameFull: Grothe JH – PersonEntity: Name: NameFull: Heringer S – PersonEntity: Name: NameFull: Cornely OA IsPartOfRelationships: – BibEntity: Dates: – D: 28 M: 11 Text: 2022 Nov 28 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1460-2091 Numbering: – Type: volume Value: 77 – Type: issue Value: 12 Titles: – TitleFull: The Journal of antimicrobial chemotherapy Type: main |
| ResultId | 1 |